Investing.com - Ionis Pharma reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Ionis Pharma announced earnings per share of $-0.33 on revenue of $160M. Analysts polled by Investing.com anticipated EPS of $-0.72 on revenue of $145.75M.
Ionis Pharma shares are down 16.73% from the beginning of the year , still down 13.46% from its 52 week high of $48.82 set on Monday, September 12, 2022.
Ionis Pharma shares gained 2.60% in pre-market trade the report.
Ionis Pharma follows other major Healthcare sector earnings this month
Ionis Pharma's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar